1018674-83-3

Basic information

• Product Name: N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide
• Synonyms: N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide;N-[2-[6-[[(3,4-Dichlorophenyl)methyl]amino]-2-(4-methoxyphenyl)-3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-4-yl]ethyl]acetamide
• CAS NO: 1018674-83-3
• Molecular Formula: C₂₅H₂₃Cl₂N₅O₃
• Molecular Weight: 512.38782
• Product Categories: Aromatics, Inhibitors
• Mol File: 1018674-83-3.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Density: 1.39±0.1 g/cm3(Predicted)
• PKA: 15.58±0.46(Predicted)
• CAS DataBase Reference: N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide(1018674-83-3)
• EPA Substance Registry System: N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide(1018674-83-3)

Safety Data

• Hazardous Substances Data: 1018674-83-3(Hazardous Substances Data)

Usage

Uses

This compound, referred to as CVT-11125, is a potent SCD inhibitor and is an important study tool in cell metabolism.

Upstream product

• 1018674-64-0 N-(2-(6-(3,4-dichlorobenzylamino)-3-nitro-pyridin-2-ylamino)ethyl)acetamide 
• 40140-16-7 ethyl (p-methoxyphenyl)oxoacetate 

Downstream Products

• 1018675-14-3 4-(2-aminoethyl)-6-{[(3,4-dichlorophenyl)methyl]amino}-2-(4-methoxyphenyl)-4-hydro-pyridino[3,2-b]pyrazin-3-one 

Relevant articles and documents

BICYCLIC NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL COA DESATURASE INHIBITORS

The present invention discloses bicyclic nitrogen-containing heterocyclic compounds for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.